Tissue metabolic activity visualization

Tissue metabolic activity visualization encompasses various imaging modalities, including positron emission tomography (PET), magnetic resonance spectroscopy/imaging (MRS/MRSI), mass spectrometry imaging (MSI), and optical imaging methods, which enable noninvasive or minimally invasive measurement of metabolic processes in tissues[1][2][3][4][5]. These methods use specialized tracers (like [18F]fluoro-deoxyglucose for PET), fluorescent indicators (such as TMRE for mitochondrial membrane potential and 2-NBDG for glucose uptake), endogenous autofluorescence (NAD(P)H, FAD), or isotope labeling to assess tissue-level processes such as glycolysis, redox state, and mitochondrial activity—valuable for studying disease mechanisms, diagnosis, and therapy response in cancer, neurodegeneration, and other conditions[1][2][3][4][5]. However, "Tissue metabolic activity visualization" refers to a set of tools and approaches—not a single molecular therapeutic target or receptor. If you require information about a specific molecule or receptor involved in tissue metabolic activity, please clarify or provide the molecule's name.

Other names

Metabolic imagingMetabolopticsIn vivo metabolic visualizationSpatial metabolomics